Effect of plasminogen activator inhibitor-1 and tissue plasminogen activator polymorphisms on susceptibility to type 2 diabetes in malaysian subjects

Effect of plasminogen activator inhibitor-1 and tissue plasminogen activator polymorphisms on susceptibility to type 2 diabetes in malaysian subjects

Elevated activity of plasminogen activator inhibitor-1 (PAI-1) and decreased tissue plasminogen activator (tPA) activity are considered to be important risk factors for type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS). The aim of this study was to investigate the association of the PAI-...

Full description

Bibliographic Details
Main Authors:	Al-Hamodi, Z., Saif-Ali, R., Ismail, I.S., Ahmed, K.A., Muniandy, S.
Format:	Article
Published:	2012
Subjects:	R Medicine

Similar Items

Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
by: Al-Hamodi, Z., et al.
Published: (2011)

Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
by: Saif-Ali Riyadh, et al.
Published: (2011-03-01)

Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian subjects
by: Al-Hamodi, Z.H., et al.
Published: (2012)

Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
by: Nurbadriah binti Jasmiad, et al.
Published: (2022-09-01)

Structural basis of specific inhibition of tissue-type plasminogen activator by plasminogen activators inhibitor-1
by: Lihu Gong, et al.
Published: (2016-03-01)

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
by: Yu Zuo, et al.
Published: (2021-01-01)

Tissue plasminogen activator and plasminogen activator inhibitor 1 contribute to sonic hedgehog-induced in vitro cerebral angiogenesis.
by: Hua Teng, et al.
Published: (2012-01-01)

Roles of tissue plasminogen activator and its inhibitor in proliferative diabetic retinopathy
by: Shu-Ling Wu, et al.
Published: (2014-10-01)

THE LEVELS OF PLASMINOGEN AND INHIBITOR OF PLASMINOGEN ACTIVATORS OF TYPE 1 IN ANTIPHOSPHOLIPID SYNDROME
by: E V Ostryakova, et al.
Published: (2012-05-01)

The neurotoxicity of tissue plasminogen activator?
by: Kaur, J, et al.
Published: (2004)

Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation
by: Kamlesh K. Gupta, et al.
Published: (2017-03-01)

The effect of anti-human plasminogen monoclonal antibodies on Glu-plasminogen activation by plasminogen activators
by: M. Akrami, et al.
Published: (2006-07-01)

Association of Celiac Disease and Plasminogen Activator Inhibitor-1 Polymorphism
by: Nur Ramoğlu, et al.
Published: (2022-10-01)

KCNQ1 variants associate with type 2 diabetes in Malaysian Malay subjects
by: Saif-Ali, R., et al.
Published: (2011)

Fibrinolysis regulation by platelets retaining plasminogen and tissue-type plasminogen activator on their surface
by: T. Grinenko, et al.
Published: (2019-12-01)

The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays.
by: Marlien Pieters, et al.
Published: (2017-01-01)

TISSUE PLASMINOGEN-ACTIVATOR VERSUS UROKINASE
by: Ebers, G
Published: (1988)

Association of DPP4 gene polymorphisms with type 2 diabetes mellitus in Malaysian subjects
by: Ahmed, R.H., et al.
Published: (2016)

Characterization of plasmin, plasminogen and plasminogen activator in goat milk
by: F. Polidori, et al.
Published: (2011-03-01)

Urokinase-type Plasminogen Activator and Plasminogen Activator Inhibitor Induction by Etoposide in a Glioblastoma Cell Strain
by: Branko Brdar, et al.
Published: (2002-01-01)

The different expressions of urokinasetype plasminogen activator, urokinasetype plasminogen activator receptor, and plasminogen activator inhibitor-1. Several scores of cell pleomorphism, number of mitosis and keratiniza
by: Perpustakaan UGM, i-lib
Published: (2008)

Premature delivery impacts the concentration of plasminogen activators and a plasminogen activator inhibitor and the plasmin activity in human milk
by: Veronique Demers-Mathieu, et al.
Published: (2022-08-01)

Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship
by: Gaber El-Saber Batiha, et al.
Published: (2022-09-01)

Vitamin D Deficiency is Associated With Increased Plasminogen Activator Inhibitor 1/Plasminogen Activator Inhibitor 2 Ratio in Pregnancy
by: Matilde Kanstrup Andersen BA, et al.
Published: (2023-09-01)

Retraction: The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays.
by: PLOS ONE Editors
Published: (2018-01-01)

Tissue plasminogen activator mediates deleterious complement cascade activation in stroke.
by: Xue-Jun Zhao, et al.
Published: (2017-01-01)

Plasminogen activator inhibitor-1 in the evolution of stroke
by: Jovanović Zagorka B., et al.
Published: (2004-01-01)

IGF2BP2 alternative variants associated with glutamic acid decarboxylase antibodies negative diabetes in Malaysian subjects
by: Salem, S.D., et al.
Published: (2012)

Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19
by: Tetiana Yatsenko, et al.
Published: (2024-01-01)

An immunohistochemical study of the distribution of plasminogen and plasminogen activators in bullous pemphigoid.
by: Venning, V, et al.
Published: (1993)

Glucocorticoid-Responsive Tissue Plasminogen Activator (tPA) and Its Inhibitor Plasminogen Activator Inhibitor-1 (PAI-1): Relevance in Stress-Related Psychiatric Disorders
by: Marie Mennesson, et al.
Published: (2023-02-01)

KCNQ1 Haplotypes Associate with Type 2 Diabetes in Malaysian chinese subjects
by: Saif-Ali, R., et al.
Published: (2011)

Tissue Plasminogen Activator and DNase in Empyema REPLY
by: Rahman, N, et al.
Published: (2011)

Corrigendum: Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19
by: Tetiana Yatsenko, et al.
Published: (2024-03-01)

Ischaemic stroke and the recanalization drug tissue plasminogen activator interfere with antibacterial phagocyte function
by: Antje Vogelgesang, et al.
Published: (2017-07-01)

The role of plasminogen activator inhibitor-2 in pneumococcal meningitis
by: Nina C. Teske, et al.
Published: (2022-10-01)

Does plasminogen activator inhibitor-1 drive lymphangiogenesis?
by: Françoise Bruyère, et al.
Published: (2010-01-01)

Polymorphism in methylenetetrahydrofolate reductase, plasminogen activator inhibitor-1, and apolipoprotein E in hemodialysis patients
by: Al-Muhanna Fahad, et al.
Published: (2008-01-01)

Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome
by: T M Reshetniak, et al.
Published: (2013-01-01)

Tissue Plasminogen Activator Is Not Involved in Methamphetamine-Induced Neurotoxicity
by: Ayumi Fukakusa, et al.
Published: (2008-01-01)